Invivyd (IVVD) Share-based Compensation (2021 - 2025)

Invivyd (IVVD) reported Share-based Compensation of $2.6 million for Q4 2025, down 16.13% on a YoY basis from $3.1 million in Q4 2024, and down 16.56% quarter-over-quarter from $3.1 million in Q3 2025.

Invivyd (IVVD) Share-based Compensation (2021 - 2025) Analysis & Trends

Invivyd has reported Share-based Compensation for 5 years, with the latest figure at $2.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation fell 16.13% year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2025 stood at $11.6 million (down 41.17% YoY), and the FY2025 full-year result was $11.6 million, down 41.16% from the prior year.
  • Share-based Compensation for Q4 2025 stood at $2.6 million, down from $3.1 million in the prior quarter.
  • The five-year high for Share-based Compensation was $8.5 million in Q2 2024, with the low at $587000.0 in Q1 2021.
  • Historically, Share-based Compensation has averaged $4.5 million across 5 years, with a median of $4.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Share-based Compensation soared 237.82% — and 2025, when it tumbled 62.54%.
  • Invivyd's Share-based Compensation stood at $7.9 million in 2021, then declined by 24.83% to $5.9 million in 2022, then retreated by 26.44% to $4.3 million in 2023, then declined by 29.63% to $3.1 million in 2024, then declined by 16.13% to $2.6 million in 2025.
  • The last three Share-based Compensation figures came in at $2.6 million (Q4 2025), $3.1 million (Q3 2025), and $3.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Invivyd 168.41 Mn -58.28 Mn - 2.56 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.56 Mn
Dec 31, 2025 2.56 Mn
Sep 30, 2025 3.07 Mn
Sep 30, 2025 3.07 Mn
Jun 30, 2025 3.18 Mn
Jun 30, 2025 3.18 Mn
Mar 31, 2025 2.83 Mn
Mar 31, 2025 2.83 Mn
Dec 31, 2024 3.06 Mn
Dec 31, 2024 3.06 Mn
Sep 30, 2024 2.87 Mn
Sep 30, 2024 2.87 Mn
Jun 30, 2024 8.49 Mn
Jun 30, 2024 8.49 Mn
Mar 31, 2024 5.38 Mn
Mar 31, 2024 5.38 Mn
Dec 31, 2023 4.34 Mn
Dec 31, 2023 4.34 Mn
Sep 30, 2023 4.26 Mn
Sep 30, 2023 4.26 Mn